Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-K
Source: 0001640334-25-001300
Chunk: 121

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-K
Item: Item 14
Chunk 121
---
 Company’s auditor since 2025.Diamond Bar, CaliforniaJuly 24, 2025   

 F-2Table of Contents

ACRO BIOMEDICAL CO., LTD.

Balance Sheets

  December 31,  December 31,   2024  2023        ASSETS      Current Assets      Cash $476  $376 Prepaid expenses  -   1,250 Security deposit  4,600   - Total Current Assets  5,076   1,626          Operating lease right of use asset  26,898   52,233 Security deposit  -   4,600 TOTAL ASSETS $31,974  $58,459          LIABILITIES AND STOCKHOLDERS’ DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $154,460  $154,444 Deferred revenue  20,000   20,000 Due to related parties  125,588   88,796 Operating lease liabilities - current  26,898   25,335 Total Current Liabilities 326,946  288,575          Operating lease liabilities - noncurrent  -   26,898 TOTAL LIABILITIES  326,946   315,473          Stockholders’ Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding  60,042   60,042 Additional paid-in capital  32,302,781   32,298,442 Accumulated deficit  (32,657,795)  (32,615,498)Total Stockholders’ Deficit  (294,972)  (257,014)         TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $31,974  $58,459 

The accompanying notes are an integral part of these financial statements.

 F-3Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

  Year ended   December 31,   2024